Latest Trials Latest NewsFAQ

Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1873-01-01

Employees: 10K

Market Cap: -

Website: http://www.vanderbilt.edu

Clinical Trials

Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis

Not Applicable

Completed

Conditions: Suspected Eosinophilic Esophagitis

Interventions: Procedure: Esophageal dilation
Drug: Steroid and Proton Pump Inhibitor Therapy

First Posted Date: 2009-04-14

Last Posted Date: 2017-11-06

Lead Sponsor: Vanderbilt University

Target Recruit Count: 50

Registration Number: NCT00880906

Locations: 🇺🇸
Vanderbilt Unversity Medical Center Department of Gastroenterology, Nashville, Tennessee, United States

Home-based Compression Therapy for Arm and Truncal Lymphedema in Breast Cancer

Not Applicable

Completed

Conditions: Truncal Lymphedema
Breast Cancer
Arm Lymphedema

Interventions: Device: Flexitouch System

First Posted Date: 2009-04-13

Last Posted Date: 2017-12-05

Lead Sponsor: Vanderbilt University

Target Recruit Count: 47

Registration Number: NCT00880022

Locations: 🇺🇸
Vanderbilt Univeristy, Nashville, Tennessee, United States

Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia

Completed

Conditions: Type 2 Diabetes

First Posted Date: 2009-04-09

Last Posted Date: 2009-09-14

Lead Sponsor: Vanderbilt University

Target Recruit Count: 219

Registration Number: NCT00879125

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

Phase 3

Terminated

Conditions: Oxidative Stress
Endothelial Dysfunction

Interventions: Drug: valsartan (ARB)
Drug: ramipril (ACE inhibitor)
Drug: Placebo

First Posted Date: 2009-04-09

Last Posted Date: 2016-02-15

Lead Sponsor: Vanderbilt University

Target Recruit Count: 78

Registration Number: NCT00878969

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab

Completed

Conditions: Breast Cancer
Cardiovascular Complications
Cardiac Toxicity

First Posted Date: 2009-04-03

Last Posted Date: 2018-02-19

Lead Sponsor: Vanderbilt University

Target Recruit Count: 133

Registration Number: NCT00875238

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
MBCCOP - Meharry Medical College - Nashville, Nashville, Tennessee, United States
🇺🇸
Vanderbilt Heart One Hundred Oaks, Nashville, Tennessee, United States

and more 1 locations

Brief Primary Care Intervention Helps Parents With Discipline

Not Applicable

Completed

Conditions: Discipline

Interventions: Behavioral: Control
Behavioral: Play Nicely program

First Posted Date: 2009-04-03

Last Posted Date: 2011-10-28

Lead Sponsor: Vanderbilt University

Target Recruit Count: 258

Registration Number: NCT00875303

Locations: 🇺🇸
Vanderbilt Pediatric Primary Care Clinic, Nashville, Tennessee, United States

The Effect of a Peroxisome Proliferator-activated Receptor (PPAR) Alpha Agonist on Cytochrome P450 (CYP) Monooxygenase Activity in Humans

Phase 4

Completed

Conditions: Hypertension

Interventions: Drug: fenofibrate
Drug: Placebo

First Posted Date: 2009-03-31

Last Posted Date: 2013-06-28

Lead Sponsor: Vanderbilt University

Target Recruit Count: 75

Registration Number: NCT00872599

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Tissue-Type Plasminogen Activator (t-PA) Release Predicts Major Adverse Cardiac Events (MACE) in Patients With Non-critical Coronary Artery Disease

Phase 1

Terminated

Conditions: Coronary Artery Disease

Interventions: Drug: Bradykinin

First Posted Date: 2009-03-25

Last Posted Date: 2017-12-13

Lead Sponsor: Vanderbilt University

Target Recruit Count: 16

Registration Number: NCT00868855

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Thrombin Regulated Platelet Activation

Completed

Conditions: Acute Coronary Syndrome
Coronary Artery Disease

First Posted Date: 2009-03-04

Last Posted Date: 2017-04-11

Lead Sponsor: Vanderbilt University

Target Recruit Count: 69

Registration Number: NCT00855296

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

PAR Regulation of Platelet Function in Diabetic Patients

Completed

Conditions: Coronary Artery Disease
Diabetes
Metabolic Syndrome
Acute Coronary Syndrome

First Posted Date: 2009-03-04

Last Posted Date: 2017-04-11

Lead Sponsor: Vanderbilt University

Target Recruit Count: 195

Registration Number: NCT00855374

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy